1Piacentini GL,Kaliner MA.The potential roles of leukotrienes in bronchial asthma[].The American Review of Respiratory Disease.1991
2Bateman ED,Aitchison JA,Summerton L,et al.The early onset of action of zafirlukast (‘Accolate’) in patients with asthma[].American Journal of Respiratory and Critical Care Medicine.1997
3Hui KP,Barnes NC.Lung function improvement in asthmatics with a cysteinyl-leukotriene receptor antagonist[].The Lancet.1991
4Tamaoki J,Kondo M,Sakai N,et al.Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose in-haled corticosteroiod[].American Journal of Respiratory and Critical Care Medicine.1997
6Andeson GP,Coyle AJ.THI and TH2 link cells in allergy and asthma.,pharmacological perspectives[J].Trends Pharm Sci,1994,25 (4):324-332.
7Bisgaard H,Nielsen KG.Bronchoprotection with a leukotriene receptor antagonise in asthmatic preschool children[J].Am J Respir Crit Care Med,2000,162(3):187-190.
8Birring SS,Parker D,Brightling CE,et al.Induced sputum in flammatory mediator concentrmions in chronic cough[J].Am J Respir Crit Care Med,2004,169(1):15-19.
9Dicpingaitis PV,Dobkin JB.Reichd J.Antitussive effect of the leukotriene receptor antagonht zafiflukast in subjects with cough-variant asthma[J].Jasthma.2002,39(4):291-297.
